Pelosi pricing plan will yield 100 fewer new drugs White House predicts

As debate over drug pricing proposals rolls on in Washington, White House advisers have concluded House Speaker Nancy Pelosi's aggressive pricing plan would result in 100 fewer new drugs over a decade, lowering Americans' expected lifespan along the way. Unveiled this fall, Pelosi's plan calls for Medicare price negotiations, an international pricing index, potential fines for drugmakers who won't negotiate and more. President Donald Trump originally tweeted that it was “great to see” the plan, but more recently, the White House has backed away from the proposal and instead supported a bipartisan effort in the Senate.